KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Aquestive Therapeutics (AQST) Inventory Average (2018 - 2025)

Aquestive Therapeutics has reported Inventory Average over the past 8 years, most recently at $7.0 million for Q4 2025.

  • Quarterly results put Inventory Average at $7.0 million for Q4 2025, up 7.56% from a year ago — trailing twelve months through Dec 2025 was $7.0 million (up 7.56% YoY), and the annual figure for FY2025 was $6.1 million, down 4.68%.
  • Inventory Average for Q4 2025 was $7.0 million at Aquestive Therapeutics, down from $8.0 million in the prior quarter.
  • Over the last five years, Inventory Average for AQST hit a ceiling of $8.0 million in Q3 2025 and a floor of $2.6 million in Q1 2021.
  • Median Inventory Average over the past 5 years was $6.5 million (2023), compared with a mean of $5.8 million.
  • Biggest five-year swings in Inventory Average: dropped 11.54% in 2021 and later surged 105.77% in 2022.
  • Aquestive Therapeutics' Inventory Average stood at $3.5 million in 2021, then surged by 81.21% to $6.3 million in 2022, then increased by 10.74% to $6.9 million in 2023, then decreased by 5.65% to $6.5 million in 2024, then increased by 7.56% to $7.0 million in 2025.
  • The last three reported values for Inventory Average were $7.0 million (Q4 2025), $8.0 million (Q3 2025), and $7.7 million (Q2 2025) per Business Quant data.